Alzinova announces positive safety review and continuation of its Phase 1b study in Alzheimer's disease

/PRNewswire/ -- Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments for Alzheimer's disease by specifically targeting...

Related Keywords

Sweden ,Finland ,Stockholm ,Swedish ,Kristina Torfg ,Sahlgrenska University Hospital In Gothenburg ,Clinical Research Services Turku ,Safety Monitoring Board ,First In Human ,Sahlgrenska University Hospital ,Certified Advisor ,Nasdaq First North Growth Market ,